Author

Marissa Allinder

Observed name: M. Allinder

Institution: ImmunityBio (United States)

Observed institutions: Medical University of South Carolina, GlaxoSmithKline (United States), ImmunityBio (United States)

ORCID: 0009-0008-2715-5762

Observed ORCID: 0009-0008-2715-5762

OpenAlex ID: A5032904802

Uroliths composed of antiviral compound GS-441524 in 2 cats undergoing treatment for feline infectious peritonitis

2023 · Marissa Allinder, Beth Tynan, et al. · Journal of Veterinary Internal Medicine · 22

First analytical confirmation of drug-induced crystal nephropathy in felines caused by GS-441524, the active metabolite of Remdesivir

2024 · Amelia Furbish, Marissa Allinder, et al. · Journal of Pharmaceutical and Biomedical Analysis · 12

2825P First-in-class lymphocyte stimulating agent (LSA) nogapendekin alfa inbakicept (NAI) increases absolute lymphocyte count (ALC) in randomized trial in non-small cell lung cancer (NSCLC)

2025 · C. Nangia, P. Soon-Shiong, et al. · Annals of Oncology

First Analytical Confirmation of Drug-Induced Crystal Nephropathy in Felines Caused by GS-441524, the Active Metabolite of Remdesivir

2024 · Amelia Furbish, Marissa Allinder, et al. · SSRN Electronic Journal

First Analytical Confirmation of Drug-Induced Crystal Nephropathy in Felines Caused by Gs-441524, the Active Metabolite of Remdesivir

2024 · Amelia Furbish, Marissa Allinder, et al. · SSRN Electronic Journal

Real-World Use of Rescue Inhaler Sensors, Electronic Symptom Questionnaires and Physical Activity Monitors in COPD Subjects

2019 · A.L. Miller, R.P. Bowler, et al. · American Journal of Respiratory and Critical Care Medicine

Comparison of Weekend and Weekday Physical Activity Patterns in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Participants by Daily Activity Level

2019 · N. Locantore, R.P. Bowler, et al. · American Journal of Respiratory and Critical Care Medicine

Works count: 7

Citation count: 34

H-index: 2

I10-index: 2